<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Blood Test Biomarkers &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/blood-test-biomarkers/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 23 Sep 2025 04:35:39 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Blood Test Biomarkers &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>How Blood Tests Are Transforming Spinal Cord Injury Recovery</title>
		<link>https://bioengineer.org/how-blood-tests-are-transforming-spinal-cord-injury-recovery/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 23 Sep 2025 04:35:21 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Blood Test Biomarkers]]></category>
		<category><![CDATA[data-driven medicine]]></category>
		<category><![CDATA[Machine Learning in Healthcare]]></category>
		<category><![CDATA[predictive analytics in critical care]]></category>
		<category><![CDATA[spinal cord injury prognosis]]></category>
		<guid isPermaLink="false">https://bioengineer.org/how-blood-tests-are-transforming-spinal-cord-injury-recovery/</guid>

					<description><![CDATA[Recent advances in artificial intelligence and data analytics are reshaping our ability to predict patient outcomes in critical care, and one of the most promising frontiers lies in the routine blood tests that hospitals conduct daily. A groundbreaking study from the University of Waterloo has demonstrated how these common blood samples can be harnessed to [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">271288</post-id>	</item>
		<item>
		<title>Breakthrough AI Tool Leverages Routine Blood Tests to Forecast Immunotherapy Outcomes Across Diverse Cancers</title>
		<link>https://bioengineer.org/breakthrough-ai-tool-leverages-routine-blood-tests-to-forecast-immunotherapy-outcomes-across-diverse-cancers/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 06 Jan 2025 20:29:00 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Artificial intelligence in oncology]]></category>
		<category><![CDATA[Blood Test Biomarkers]]></category>
		<category><![CDATA[Cancer Treatment Accessibility]]></category>
		<category><![CDATA[Immunotherapy Response Prediction]]></category>
		<category><![CDATA[Machine Learning in Healthcare]]></category>
		<guid isPermaLink="false">https://bioengineer.org/breakthrough-ai-tool-leverages-routine-blood-tests-to-forecast-immunotherapy-outcomes-across-diverse-cancers/</guid>

					<description><![CDATA[In a significant advancement for cancer treatment, researchers have unveiled a groundbreaking model designed to enhance the prediction of patient responses to immune checkpoint inhibitors. These inhibitors represent a class of drugs within immunotherapy that have demonstrated remarkable potential in cancer management. However, they are not effective for everyone, which has prompted a global need [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">233161</post-id>	</item>
	</channel>
</rss>
